Company Filing History:
2 out of 4 
2 out of 1,743 
2 out of 5,076 
Years Active: 2021-2023
Title: Loic Mathieu: Innovator in ERK Kinase Inhibitors
Introduction
Loic Mathieu is a prominent inventor based in Montpellier, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target ERK kinase activity. With a total of 2 patents to his name, Mathieu's work is paving the way for advancements in therapeutic applications.
Latest Patents
Mathieu's latest patents include innovative compounds known as Azaindole derivatives and their use as ERK kinase inhibitors. The first patent concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, specifically designed to inhibit ERK kinase activity, particularly ERK2 activity. This invention also encompasses prodrugs of these compounds. The second patent focuses on Zaindole derivatives, which similarly serve as ERK kinase inhibitors, highlighting the potential of these compounds in medical applications.
Career Highlights
Throughout his career, Loic Mathieu has worked with notable organizations such as Agv Discovery and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to refine his expertise in drug development and innovation.
Collaborations
Mathieu has collaborated with esteemed colleagues, including Jean-François Guichou and Cédric Bories. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Loic Mathieu's contributions to the field of medicinal chemistry, particularly through his patents on ERK kinase inhibitors, demonstrate his commitment to innovation and research. His work continues to influence the development of new therapeutic strategies.